| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 02/09/2012 | US20120035113 Methods of reducing trail-induced apoptosis by trail isoforms |
| 02/09/2012 | US20120035108 Spray base material including low-molecular gelator |
| 02/09/2012 | US20120034651 Akt activity specifically inhibiting polypeptide |
| 02/09/2012 | US20120034609 Gene detection assay for improving the likelihood of an effective response to an egfr antagonist cancer therapy |
| 02/09/2012 | US20120034298 Chewable Soft Capsule |
| 02/09/2012 | US20120034243 Method of Administering an Antibody |
| 02/09/2012 | US20120034213 TREATMENT WITH ANTI-ErbB2 ANTIBODIES |
| 02/09/2012 | US20120034193 Treatment of neurotrophic factor mediated disorders |
| 02/09/2012 | US20120034164 Truncated car peptides and methods and compositions using truncated car peptides |
| 02/09/2012 | US20120034159 Antibodies that bind both bcma and taci |
| 02/09/2012 | CA2810150A1 P2x4 receptor antagonist |
| 02/09/2012 | CA2807459A1 Process for preparing a compound by a novel sandmeyer-like reaction using a nitroxide radical compound as a reaction catalyst |
| 02/09/2012 | CA2807224A1 Preparation for treatment of spinal cord injury |
| 02/09/2012 | CA2806636A1 Use of glyceryl trinitrate for treating traumatic edema |
| 02/08/2012 | EP2415870A1 Rnai molecule for thymidylate synthase and use thereof |
| 02/08/2012 | EP2415771A1 Indolizine derivative and use thereof for medical purposes |
| 02/08/2012 | EP2415764A1 Prophylactic and/or therapeutic agent for anemia comprising tetrahydroquinoline compound as active ingredient |
| 02/08/2012 | EP2415760A2 CCR-9 antagonists |
| 02/08/2012 | EP2415756A1 Isothiourea derivatives or isourea derivatives having bace1 inhibitory activity |
| 02/08/2012 | EP2415748A1 Novel anti-inflammatory compounds |
| 02/08/2012 | EP2415486A2 Conjugates and compositions for cellular delivery |
| 02/08/2012 | EP2415478A1 Prophylactic or therapeutic agent for retinal diseases and method for preventing or treating retinal diseases, each comprising jnk (c-jun n-terminal kinase)-inhibiting peptide, and use of the peptide |
| 02/08/2012 | EP2415473A1 Oral Care Compositions Containing Combinations of Anti-Bacterial and Host-Response Modulating Agents |
| 02/08/2012 | EP2415462A1 Improved pharmaceutical compositions for poorly soluble drugs |
| 02/08/2012 | EP2414372A1 Chemical synthesis of phosphatidylinositol mannoside glycans from mycobacterium tuberculosis |
| 02/08/2012 | EP2414332A1 Acrylamide compounds and the use thereof |
| 02/08/2012 | EP2102235B1 Treatment of cachexia |
| 02/08/2012 | EP1509518B1 Calcium receptor modulating agents |
| 02/08/2012 | CN1652757B Edg受体结合剂在癌症中的应用 Edg receptor binding agents in cancer of the |
| 02/08/2012 | CN102348796A Novel cancer antigen eEF2 |
| 02/08/2012 | CN102348459A Plasma-adapted full electrolyte solution |
| 02/08/2012 | CN102343034A Composition applied to side effects caused by tumor radiation and pharyngitis |
| 02/08/2012 | CN102342966A Traditional Chinese medicine medicinal liquor formula containing ginseng, glossy ganoderma, pilos antler and five animal rib |
| 02/08/2012 | CN102342938A Methods and compositions for treatment and management of cancers |
| 02/08/2012 | CN102085298B 治疗猪高温高热病的药物 High temperature treatment of swine fever drugs |
| 02/08/2012 | CN101991568B 洋川芎内酯i在制备抗抑郁症药物、偏头痛药物及其他5-羟色胺能系统相关疾病药物中的应用 Yang Chuan Xiong lactone i in the preparation of antidepressants, migraine drugs and other serotonergic system-related diseases can medicament |
| 02/08/2012 | CN101522665B *庚英衍生物 * Geng Ying derivatives |
| 02/07/2012 | US8110598 Heterocyclic compounds, their preparation, pharmaceutical compositions containing them and their use in medicine |
| 02/07/2012 | US8110587 Aryl ureas as kinase inhibitors |
| 02/07/2012 | US8110567 Phenyl-piperazine derivatives as serotonin reuptake inhibitors |
| 02/07/2012 | US8110565 Of the ACE inhibitor ramipril; controlling the melting point by mixing with the free acid with the ramipril ethyl or methyl ester prodrug and a pressure sensitive adhesive carrier; improved pharmacokinetics; sustained release |
| 02/07/2012 | US8110564 Bile acid or bile salt fatty acid conjugates |
| 02/07/2012 | US8110378 Nucleic acids encoding DCRS5 |
| 02/07/2012 | US8110189 Using monoclonal antibody specific to biliary glycoprotein as tool in treatment and prevention of cell proliferative, autoimmune, immunodeficiency and transplant rejection disorders |
| 02/07/2012 | CA2492404C Piperidinetriol derivatives as inhibitors of glycosylceramide synthase |
| 02/07/2012 | CA2488535C Glucocorticoid receptor ligands for the treatment of metabolic disorders |
| 02/07/2012 | CA2486144C Compositions comprising an angiotensin receptor blocker, a calcium channel blocker and a diuretic |
| 02/07/2012 | CA2471044C Benzimidazole derivatives and their use as gnrh antagonists |
| 02/07/2012 | CA2465906C Method and apparatus for the stimulation of hair growth |
| 02/07/2012 | CA2460655C Combination of selected opioids with muscarine antagonists for treating urinary incontinence |
| 02/07/2012 | CA2383850C Prevention and treatment of mycoplasma-associated diseases |
| 02/07/2012 | CA2225898C Enhancing keratinocyte migration and proliferation |
| 02/02/2012 | WO2012015820A1 Composition and method for photodynamic disinfection |
| 02/02/2012 | WO2012015037A1 Antimicrobial activity enhancing agent |
| 02/02/2012 | WO2012015027A1 Therapeutic agent or prophylactic agent for neuropathic pain |
| 02/02/2012 | WO2012015024A1 Ethinyl-pyrazole derivative |
| 02/02/2012 | WO2012014994A1 Naphthalene derivative |
| 02/02/2012 | WO2012014993A1 Agent for increasing translation initiation factor or translation elongation factor, and use thereof for medical purposes |
| 02/02/2012 | WO2012014971A1 Lactic bacterium having an effect of ameliorating metabolic syndrome |
| 02/02/2012 | WO2012014963A1 Condensed ring pyridine compound |
| 02/02/2012 | WO2012014936A1 Cancer stem cell differentiation inducer |
| 02/02/2012 | WO2012014910A1 P2x4 receptor antagonist |
| 02/02/2012 | WO2012014890A1 NUCLEIC ACID MOLECULE CAPABLE OF BINDING TO c-Met AND USE THEREOF |
| 02/02/2012 | WO2012014848A1 Flavoniod-derived hes-1 promoter inhibitor |
| 02/02/2012 | WO2012014805A1 Nitric oxide generation regulator |
| 02/02/2012 | WO2012014699A1 Therapeutic agent for neurological diseases |
| 02/02/2012 | WO2012014417A1 Use of plant or like for improving pores, method for improving pores and oral preparation for improving pores |
| 02/02/2012 | WO2012013750A1 Use of dronedarone for the preparation of a medicament for the hospitalization burden in patient with atrial fibrillation |
| 02/02/2012 | WO2011145105A3 Herbal composition for treatment of filariasis |
| 02/02/2012 | US20120029074 Controlling transgene expression across the skin |
| 02/02/2012 | US20120029061 Rna sequence-specific mediators of rna interference |
| 02/02/2012 | US20120028987 Bicyclic Benzamides of 3-Or-4-Substituted 4-(Aminomethyl)-Piperidine Derivatives |
| 02/02/2012 | US20120028982 2-amino-bicyclo[3.1.0]hexane-2, 6-dicarboxylic ester derivative |
| 02/02/2012 | US20120028939 Substituted naphthyridines and their use as medicaments |
| 02/02/2012 | US20120028931 Heterocyclic m-glu5 antagonists |
| 02/02/2012 | US20120028882 Method for removing endotoxin from proteins |
| 02/02/2012 | US20120028300 Whitefly Ecdysone Receptor Nucleic Acids, Polypeptides, and Uses Thereof |
| 02/02/2012 | US20120028281 Inhibition of migration inhibitory factor in the treatment of diseases involving cytokine-mediated toxicity |
| 02/02/2012 | US20120027860 Encapsulated adipose-derived stem cells, methods for preparation and theraputic use |
| 02/02/2012 | US20120027835 Surgical prosthesis having biodegradable and nonbiodegradable regions |
| 02/02/2012 | US20120027825 Method of preparing lipid nanoparticles |
| 02/02/2012 | US20120027792 Expression vectors able to elicit improved immune response and methods of using same |
| 02/02/2012 | US20120027777 Ljungan virus with improved replication characteristics |
| 02/02/2012 | US20120027769 Anti-rhd monoclonal antibodies |
| 02/02/2012 | US20120027751 Antagonists of tweak and of tweak receptor and their use to treat immunological disorders |
| 02/02/2012 | US20120027706 Methods for treating skin pigmentation |
| 02/02/2012 | US20120027689 Methods and compositions for altering photophysical properites of fluorophores via proximal quenching |
| 02/02/2012 | CA2809113A1 P2x4 receptor antagonist |
| 02/02/2012 | CA2806821A1 Fused ring pyridine compound |
| 02/02/2012 | CA2806766A1 Therapeutic agent for neurological diseases |
| 02/02/2012 | CA2806094A1 Composition and method for photodynamic disinfection |
| 02/02/2012 | CA2805371A1 Therapeutic agent or prophylactic agent for neuropathic pain |
| 02/01/2012 | EP2412805A1 Gene involved in immortalization of human cancer cell and use thereof |
| 02/01/2012 | EP2412797A1 Process for producing lactic acid bacterium having enhanced immunomodulating activity |
| 02/01/2012 | EP2412710A1 Fused piperidine compound and pharmaceutical agent comprising same |
| 02/01/2012 | EP2412708A1 Substituted 3-hydroxy-4-pyridone derivative |
| 02/01/2012 | EP2412705A1 Novel therapeutic agent for cognitive impairment |
| 02/01/2012 | EP2412701A1 Novel amide derivative and skin whitening agent |
| 02/01/2012 | EP2412700A1 Method for producing bicyclic gamma-amino acid derivative |
| 02/01/2012 | EP2412375A1 Pharmaceutical composition for prevention or treatment of lifestyle-related disease, and food useful for prevention or treatment of lifestyle-related disease |